相关实验视频
Updated: Feb 17, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.7K
综合多组学阐明了双A在恶化克罗恩病中的分子机制
Liangliang Dai1,2, Chenjie Qiu3
1Department of Urology, Wujin Hospital Affiliated With Jiangsu University, Changzhou, 213004, China, ujs.edu.cn.
Mediators of inflammation
|February 16, 2026
概括
双甲 (BPA) 暴露可能会通过影响参与炎症和免疫反应的关键基因,使克罗恩病 (CD) 恶化. 这项研究确定了五个核心基因和CD的潜在治疗点.
科学领域:
- 环境健康 环境健康
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
背景情况:
- 双A (BPA) 是一种内分泌干扰化学物质,与克罗恩氏病 (CD) 的进展有关.
- BPA对CD影响的精确分子机制尚不清楚.
研究的目的:
- 系统地阐明BPA是如何加剧CD的.
- 确定由BPA影响的CD的关键生物标志物和治疗点.
主要方法:
- 对BPA目标和CD转录组数据的综合分析.
- 功能丰富,蛋白质-蛋白质相互作用 (PPI) 网络和机器学习分析以识别核心基因.
- 分子对接,免疫透和调控网络分析以探索分子机制.
主要成果:
- 鉴定了BPA和CD之间65个重叠的基因,富含炎症和免疫通路.
- 选了具有诊断潜力的五个核心基因 (HGF,IL1R1,MMP1,MMP2,NTRK2).
- 证实了BPA与核心蛋白质 (例如MMP2) 之间强烈的结合亲和力,并将核心基因与免疫细胞和调节因素联系起来.
结论:
- BPA可能会通过破坏炎症平衡,细胞外基因重塑和通过核心基因进行免疫平衡来恶化CD.
- 确定了HGF,IL1R1,MMP1,MMP2和NTRK2作为潜在的生物标志物和BPA诱导的CD的治疗标.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Chronic Bowel Disorders: Introduction
817
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
817
Irritable Bowel Syndrome I: Introduction
1.2K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915
Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
600
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
600

